261723-28-8

Basic information

• Product Name: (3-bromo-2-fluorophenyl)methanamine
• Synonyms: (3-bromo-2-fluorophenyl)methanamine;(3-Bromo-2-fluorophenyl);3-Bromo-2-fluoro-benzylamine
• CAS NO: 261723-28-8
• Molecular Formula: C₇H₇BrFN
• Molecular Weight: 204.0395832
• Mol File: 261723-28-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 245.2±25.0 °C(Predicted)
• Appearance: /
• Density: 1.571±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 8.35±0.10(Predicted)
• CAS DataBase Reference: (3-bromo-2-fluorophenyl)methanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (3-bromo-2-fluorophenyl)methanamine(261723-28-8)
• EPA Substance Registry System: (3-bromo-2-fluorophenyl)methanamine(261723-28-8)

Safety Data

• Hazardous Substances Data: 261723-28-8(Hazardous Substances Data)

Usage

General Description

(3-bromo-2-fluorophenyl)methanamine is a chemical compound with the molecular formula C7H6BrFN that consists of a benzene ring with a bromine atom in the 3-position, a fluorine atom in the 2-position, and a methanamine group attached to the benzene ring. (3-bromo-2-fluorophenyl)methanamine is used as a building block in organic synthesis and can be utilized to create a variety of other chemical compounds. It is important to handle (3-bromo-2-fluorophenyl)methanamine with care as it may be hazardous if not properly used or stored and should only be handled by individuals with the appropriate training and equipment.

InChI:InChI=1/C7H7BrFN.ClH/c8-6-3-1-2-5(4-10)7(6)9;/h1-3H,4,10H2;1H

Upstream product

• 261723-32-4 1-bromo-2-fluoro-3-(hydroxymethyl)benzene 
• 1072-85-1 o-fluorobromobenzene 
• 374554-41-3 3-bromo-2-fluorobenzoyl chloride 
• 161957-56-8 3-bromo-2-fluorobenzoic acid 
• 871353-25-2 3-bromo-2-fluorophenylamide 

Downstream Products

• 1177558-58-5 1,1-dimethylethyl [(3-bromo-2-fluorophenyl)methyl]carbamate 

Relevant articles and documents

NOVEL ANTIBIOTICS AND METHODS OF USING SAME

The present invention includes novel 3,6-diazabicyclo[3.1.1]heptane antibiotic compounds and any salts or solvates thereof. The present invention further includes methods of preparing such compounds, and methods of treating bacterial infection in a subjec

Dual Pharmacophores - PDE4-Muscarinic Antagonistics

The present invention is directed to novel compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions and their use as dual chromaphores having inhibitory activity against PDE4 and muscarinic acetylcholine receptors (mAChRs), and thus being useful for treating respiratory diseases.

Dual Pharmacophores - PDE4-Muscarinic Antagonistics

The present invention is directed to novel compounds of Formula (I), pharmaceutical compositions and their use in therapy, for example as inhibitors of phosphodiesterase type IV (PDE4) and as antagonists of muscarinic acetylcholine receptors (mAChRs), in the treatment of/and or prophylaxis of respiratory diseases, including antiinflammatory and/or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rhinitis (e.g. allergic rhinitis), atopic dermatitis or psoriasis.